Skip to Content
myAACR
Donate Today

Progress Against Cancer

Home » Patients, Caregivers, and Advocates » Progress Against Cancer » Research

Recent Progress: FDA Approvals

A New Therapy for Bladder Cancer 

A New Therapy for Bladder Cancer 

The FDA granted accelerated approval to the targeted therapeutic sacituzumab govitecan to treat certain patients with the most common form of bladder cancer.    The U.S. Food and Drug Administration (FDA) recently granted accelerated approval...